Arizona Center For Clinical Trials LLC is categorized under Medical Labs in Cave Creek, AZ and active since 2009.
Arizona Center For Clinical Trials LLC was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Eufronio C Roman at the company’s single location by writing to 27621 North 47th St, Cave Creek, Arizona AZ 85331 or by phoning (480) 585-2986. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Arizona Center For Clinical Trials LLC |
| Contact Person: | Eufronio C Roman |
| Address: | 27621 North 47th St, Cave Creek, Arizona 85331 |
| Phone Number: | (480) 585-2986 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Arizona Center For Clinical Trials LLC was started in 2009 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Eufronio C Roman for inquiries that concern Arizona Center For Clinical Trials LLC by calling the company number (480) 585-2986, as your correspondence is most welcome. Additionally, the physical location of the single location of Arizona Center For Clinical Trials LLC can be found at the coordinates 33.736457,-111.978795 as well as the street address 27621 North 47th St in Cave Creek, Arizona 85331.
For its online presence, you may visit Arizona Center For Clinical Trials LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.